Vext Announces Voting Results of Annual General Meeting
MWN-AI** Summary
Vext Science, Inc. (CSE: VEXT; OTCQX: VEXTF), a prominent U.S.-based cannabis company with operations in Arizona and Ohio, successfully held its annual general meeting (AGM) on December 11, 2025, in Vancouver, British Columbia. The company announced that shareholders showed overwhelming support for all agenda items presented during the meeting, with each resolution passing by a remarkable majority of over 97% based on the votes cast. Notably, approximately 74% of the outstanding shares were represented in this voting process.
Vext Science operates vertically integrated cannabis businesses, encompassing cultivation, manufacturing, and retail operations. The company boasts state-of-the-art facilities in both Arizona and Ohio, producing a wide range of products under its well-regarded Vapen™ brand. This brand includes popular THC concentrates, edibles, and distillate cartridges, which are crafted from high-quality, in-house grown flower and distributed across its key markets.
The leadership team at Vext brings considerable expertise in managing profitable multi-state operations. With a commitment to innovation, Vext aims to enhance its offerings and customer experience while simultaneously driving shareholder value. The company is keen on expanding its footprint in its primary markets of Arizona and Ohio, leveraging cutting-edge science and effective marketing strategies.
Vext Science is listed on the Canadian Securities Exchange under the ticker symbol VEXT and is also traded on the OTCQX under VEXTF. Investors can access further information on Vext via their investor website or by contacting the investor relations team. This passing of resolutions at the AGM underscores shareholder confidence in Vext’s strategic direction and future growth potential.
MWN-AI** Analysis
Vext Science, Inc. (CSE: VEXT; OTCQX: VEXTF) recently held its annual general meeting on December 11, 2025, where shareholders overwhelmingly voted in favor of all resolutions, with over 97% support from those participating. This significant backing, which encompassed 74% of the votes associated with the outstanding shares, not only underscores the shareholders' confidence in the company's management and strategic direction but also bodes well for VEXT’s future growth prospects.
As a vertical operator in the cannabis sector, particularly within the thriving markets of Arizona and Ohio, Vext has established itself as a formidable player, showcasing robust operational capabilities from cultivation to retail. The company is known for producing Vapen™, a popular brand within the THC concentrate space, reflecting its commitment to high-quality products and branding. The endorsement of management’s proposals suggests that shareholders are aligned with Vext’s growth trajectory, focusing on enhancing its operational efficiencies and product offerings.
Investors should consider the implications of this strong shareholder support when evaluating whether to buy or hold VEXT stock. The company’s positive momentum is likely to attract further institutional interest, especially given the evolving legal landscape favoring cannabis in the U.S. market. Additionally, Vext’s emphasis on innovation and customer engagement can serve as competitive advantages in an increasingly crowded field.
However, potential investors should remain mindful of regulatory risks and market volatility characteristic of the cannabis industry. As Vext looks to expand its footprint in Arizona and Ohio, monitoring operational performance and market conditions will be critical. Overall, with a solid organizational foundation and favorable market dynamics, Vext Science is well-positioned for sustained growth and value creation in the coming years.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced final voting results from its annual general meeting of shareholders held on December 11, 2025 in Vancouver, British Columbia (the "Meeting").
The shareholders of the Company voted in favour of all matters included in the management information circular for the Meeting, demonstrating strong support for the matters brought before the Meeting, with each of the resolutions passing with over 97% of the votes cast, representing 74% of the votes associated with the issued and outstanding shares of the Company.1
For more details, visit Vext's investor website or contact the IR team at investors@vextscience.com.
About VEXT Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc.
1In total, 183,712,741 shares out of 247,683,573 shares the Company has issued and outstanding, were voted at the Meeting. The reference to "shares" means the Company's common shares and Class A shares reported on an as converted basis.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277810
FAQ**
How does Vext Science, Inc. plan to leverage its strong shareholder support from the recent meeting in Vancouver to further its expansion in Arizona and Ohio? Vext:Cc VEXT:CC
What specific challenges does Vext anticipate in maintaining its market position in the competitive cannabis landscape of British Columbia, and how are they preparing to address these? Vext:Cc VEXT:CC
Given the successful votes on all matters at the annual general meeting, what strategic initiatives will Vext Science prioritize in the next fiscal year to enhance shareholder value? Vext:Cc VEXT:CC
Can Vext provide insights into any potential plans for entering the Canadian cannabis market, particularly after their recent meeting in Vancouver? Vext:Cc VEXT:CC
**MWN-AI FAQ is based on asking OpenAI questions about Vext Science Inc. (OTC: VEXTF).
NASDAQ: VEXTF
VEXTF Trading
2.86% G/L:
$0.18 Last:
500 Volume:
$0.18 Open:



